Worldquant Millennium Advisors LLC Catalent, Inc. Transaction History

Worldquant Millennium Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $9.55 Million - $12.6 Million	-101,439 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $12.1 Million - $14.1 Million	101,439 New	101,439 $13 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $4.04 Million - $4.65 Million	-40,216 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $1.47 Million - $1.81 Million	17,162 Added 74.44%	40,216 $4.19 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $1.68 Million - $2.13 Million	23,054 New	23,054 $1.98 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.